Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-17 00:14 | 2022-12-15 | CVS | CVS HEALTH Corp | Moriarty Thomas M | Officer; EVP & General Counsel | Retail-Drug Stores and Proprietary Stores | OPT+S | $98.36 | 137,466 | $13,521,183 | 608,129 | -18.4% |
| 2022-07-01 00:00 | 2022-06-28 | CVS | CVS HEALTH Corp | Moriarty Thomas M | Officer; EVP & General Counsel | Retail-Drug Stores and Proprietary Stores | OPT+S | $95.00 | 138,654 | $13,172,130 | 626,273 | -18.1% |
| 2022-03-17 23:32 | 2022-03-15 | CVS | CVS HEALTH Corp | Moriarty Thomas M | Officer; EVP & General Counsel | Retail-Drug Stores and Proprietary Stores | OPT+S | $105.00 | 51,361 | $5,392,905 | 836,751 | -5.8% |
| 2021-05-13 00:30 | 2021-05-10 | CVS | CVS HEALTH Corp | Moriarty Thomas M | Officer; EVP & General Counsel | Retail-Drug Stores and Proprietary Stores | OPT+S | $86.00 | 109,469 | $9,414,334 | 0 | -100.0% |
| 2021-04-23 23:57 | 2021-04-21 | CVS | CVS HEALTH Corp | Moriarty Thomas M | Officer; EVP & General Counsel | Retail-Drug Stores and Proprietary Stores | OPT+S | $77.00 | 103,423 | $7,963,571 | 0 | -100.0% |
| 2021-03-31 00:01 | 2021-03-29 | CVS | CVS HEALTH Corp | Moriarty Thomas M | Officer; EVP & General Counsel | Retail-Drug Stores and Proprietary Stores | OPT+S | $76.15 | 62,943 | $4,793,109 | 0 | -100.0% |
| 2021-03-24 01:15 | 2021-03-19 | CVS | CVS HEALTH Corp | Moriarty Thomas M | Officer; EVP & General Counsel | Retail-Drug Stores and Proprietary Stores | SALE | $74.15 | 49,211 | $3,648,996 | 18,226 | -73.0% |
| 2017-10-03 23:08 | 2017-10-02 | CVS | CVS HEALTH Corp | Moriarty Thomas M | Officer; EVP & General Counsel | Retail-Drug Stores and Proprietary Stores | OPT+S | $81.17 | 20,547 | $1,667,771 | 22,631 | -47.6% |
| 2017-09-13 00:29 | 2017-09-11 | CVS | CVS HEALTH Corp | Moriarty Thomas M | Officer; EVP & General Counsel | Retail-Drug Stores and Proprietary Stores | OPT+S | $79.61 | 90,267 | $7,186,156 | 29,009 | -75.7% |
| 2012-10-03 22:32 | 2012-10-01 | CVS | CVS HEALTH Corp | Moriarty Thomas M | Officer; EVP & General Counsel | Retail-Drug Stores and Proprietary Stores | BUY | $48.67 | 6,164 | $300,002 | 6,164 | +100.0% |
| 2011-07-22 23:15 | 2011-07-21 | MHS | N/A | Moriarty Thomas M | Officer; Gen'l Counsel & Secretary, SVP | Other | OPT+S | $65.31 | 33,678 | $2,199,510 | 68,867 | -32.8% |
| 2011-02-25 00:36 | 2011-02-23 | MHS | N/A | Moriarty Thomas M | Officer; Gen'l Counsel & Secretary, SVP | Other | SALE | $61.14 | 7,992 | $488,631 | 53,267 | -13.0% |
| 2010-12-03 00:04 | 2010-12-01 | MHS | N/A | Moriarty Thomas M | Officer; Gen'l Counsel & Secretary, SVP | Other | SALE | $61.75 | 4,828 | $298,129 | 71,295 | -6.3% |
| 2010-11-24 00:26 | 2010-11-22 | MHS | N/A | Moriarty Thomas M | Officer; Gen'l Counsel & Secretary, SVP | Other | OPT+S | $61.00 | 33,678 | $2,054,358 | 80,295 | -29.5% |
| 2010-11-09 00:14 | 2010-11-05 | MHS | N/A | Moriarty Thomas M | Officer; Gen'l Counsel & Secretary, SVP | Other | OPT+S | $59.25 | 47,176 | $2,795,202 | 80,295 | -37.0% |
| 2008-03-12 20:03 | 2008-03-10 | MHS | N/A | Moriarty Thomas M | Officer; Gen'l Counsel & Secretary, SVP | Other | SALE | $42.50 | 8,120 | $345,100 | 60,078 | -11.9% |
| 2007-12-03 21:07 | 2007-11-30 | MHS | N/A | Moriarty Thomas M | Officer; Senior Vice President | Other | OPT+S | $101.39 | 5,902 | $598,433 | 22,752 | -20.6% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.